Abstract:Objective: Patients with severe hypertension can present with systemic signs of thrombotic microangiopathy (TMA), i.e., thrombocytopenia and microangiopathic hemolytic anemia (MAHA), and/or renal failure. Determining the underlying disease causing TMA is essential for selection of the optimal therapy. We aim to elucidate key factors for distinguishing TMA due to malignant hypertension from TMA due to thrombotic thrombocytopenic purpura (TTP). Design and method: We present here a case study focussing on a challenging clinical scenario involving TMA. Through detailed examination of the patient's presentation, laboratory findings, and response to treatment, the report takes you through a diagnostic journey emphasising the unique aspects of TMA in malignant hypertension as compared to TMA in TTP. Results: A 44 year old male was admitted with 2 weeks history of exertional breathlessness, orthopnea and severe headache with vomiting. On examination his BP was severely elevated at 253/150 mmHg and he had features of acute pulmonary edema (APO). Initial investigations Significant anemia (hemolytic picture with elevated LDH, low haptoglobin and Indirect hyperbilirubinemia) with thrombocytopenia. Peripheral blood film revealed fragmented RBCs(2-4/hpf), Severe renal failure Creatinine 757umol/L urea 30.9mmol/L Na 129mmol/L, K 2.6mmol/L. MRI Brain revealed features suggestive of Posterior reversible encephalopathy syndrome (PRES). He was diagnosed with hypertensive emergency complicated by APO, PRES and Acute kitney injury from MAHA. He was admitted to ICU and treated with IV GTN infusion, hydralazine and diuretics. He was also started on hemodialysis. Renal failure work-up-HbA1c 4.4, nonreactive viral markers, negative autoimmune serology (C3/C4 normal, Anti-dsDNA <25, ANA <80, ANCA negative). Secondary Hypertension work-up - negative for Renal artery stenosis, Conns, Cushings, Phaeochromocytoma and Thyroid disorders. ADAMTS-13 Activity: 28%, DCT Negative. He was closely monitored, continued on hemodialysis and his blood pressure well-controlled with consequent improvement in LDH, bilirubin, Hemoglobin, and thrombocytopenia. He did not require to be treated with plasma exchange. Conclusions: The report contributes valuable insights into the differentiation of these two related yet clinically distinct entities, providing guidance for clinicians to appropriately tailor the therapeutic interventions. Further research is essential for refining diagnostic criteria to enhancie the precision of therapeutic strategies in these complex medical scenarios.

Clinico-pathological Characteristics and Outcome of Patients with Thrombotic Microangiopathy

Risk and Prognostic Factors of Transplantation‐associated Thrombotic Microangiopathy in Allogeneic Haematopoietic Stem Cell Transplantation: a Nested Case Control Study

Evaluation the Risk Factor of Transplantation-Associated Thrombotic Microangiopathy.

Clinicopathologic Characteristics and Outcomes in Patients with Class Ⅳ Lupus Nephritis Presented with Thrombotic Microangiopathy

Clinical and Renal Biopsy Findings Predicting Outcome in Renal Thrombotic Microangiopathy: A Large Cohort Study from a Single Institute in China

Clinicopathologic Characteristics and Outcomes of Renal Thrombotic Microangiopathy in Anti-Neutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis

Clinical profile and outcomes of De novo posttransplant thrombotic microangiopathy

Clinical Characteristics and Prognosis of Diffuse Proliferative Lupus Nephritis with Thrombotic Microangiopathy.

Outcomes of Early Thrombotic Microangiopathy in Renal Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy: 16 Cases Report and Literature Review

Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.

Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study

Histopathological features of thrombotic microangiopathies in renal biopsies

Thrombotic Microangiopathies and the Kidney

Clinicopathological Features and Outcomes of SLE Patients with Renal Injury Characterised by Thrombotic Microangiopathy.

Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature

Thrombotic Microangiopathy with Concomitant GI Agvhd after Allogeneic Hematopoietic Stem Cell Transplantation: Risk Factors and Outcome

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy

New Advances in the Diagnosis and Treatment of Thrombotic Microangiopathy

The outcome of thrombotic microangiopathy in kidney transplant recipients

DECIPHERING THROMBOTIC MICROANGIOPATHY: A CASE-BASED EXPLORATION OF DISTINGUISHING FEATURES BETWEEN MALIGNANT HYPERTENSION AND THROMBOTIC THROMBOCYTOPENIC PURPURA